The Human and Animal Bridging Research Organization (HAB) is pleased to announce the opening of its new office in Shonan iPARK on August 1, 2019.
HAB was first established in 1994 under the name Human and Animal Bridge Discussion Group. Since 1996, HAB has been an international partner with National Disease Research Interchange (NDRI) in Philadelphia, Pa. USA to provide human biomaterials for Japanese researchers. Our purpose is to assist research and development of innovative therapeutics and medical products following appropriate ethical committee regulatory guidelines and review for improvement of human health. We hope to be your good partner in Shonan iPARK and to contribute to your innovative research and drug development activities at Shonan iPARK.

Katashi Fukao, M.D., Ph.D, President, Non-Profit Organization HAB Research Organization